Targeting G9a/DNMT1 methyltransferase activity impedes IGF2-mediated survival in hepatoblastoma.

Salih DemirNegin RazizadehÉmilie IndersieSophie BranchereauStefano Cairo Roland Kappler

Published in: Hepatology communications (2024)

The inhibition of UHRF1-associated epigenetic traces, such as IGF2-mediated survival, is an attractive approach to treat high-risk HB, especially when combined with the standard-of-care therapeutic cisplatin.

Keyphrases

dna methylation
healthcare
pi k akt
free survival
binding protein
gene expression
palliative care
cancer therapy
drug delivery
signaling pathway
chronic pain
health insurance
affordable care act